Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Objective: Gynecologic cancers are associated with a high risk of venous thromboembolism (VTE). The Khorana score is a validated tool to assess risk of VTE in cancer patients. The purpose of this study is to determine if the Khorana score can be used as a risk stratification tool for VTE in patients...

Full description

Bibliographic Details
Main Authors: Rachael N. Piver, Vincent M. Wagner, Monica D. Levine, Floor J. Backes, Laura J. Chambers, David E. Cohn, Larry J. Copeland, Casey M. Cosgrove, Christa I. Nagel, David M. O'Malley, Kristin L. Bixel
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Gynecologic Oncology Reports
Subjects:
Chemotherapy
Endometrial cancer
Khorana score
Thromboprophylaxis
Uterine cancer
Venous thromboembolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923000255

Internet

http://www.sciencedirect.com/science/article/pii/S2352578923000255

Similar Items